D
David E. Riley
Researcher at Case Western Reserve University
Publications - 73
Citations - 5885
David E. Riley is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Tourette syndrome & Parkinson's disease. The author has an hindex of 31, co-authored 73 publications receiving 5266 citations. Previous affiliations of David E. Riley include University Hospitals of Cleveland & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Criteria for the diagnosis of corticobasal degeneration.
Melissa J. Armstrong,Irene Litvan,Anthony E. Lang,Thomas H. Bak,Kailash P. Bhatia,Barbara Borroni,Adam L. Boxer,Dennis W. Dickson,Murray Grossman,Mark Hallett,Keith A. Josephs,Andrew Kertesz,Suzee E. Lee,Bruce L. Miller,Stephen G. Reich,David E. Riley,Eduardo Tolosa,Alexander I. Tröster,Marie Vidailhet,William J. Weiner +19 more
TL;DR: Clinical CBD phenotypes and features were combined to create 2 sets of criteria: more specific clinical research criteria for probable CBD and broader criteria for possible CBD that are more inclusive but have a higher chance to detect other tau-based pathologies.
Journal ArticleDOI
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Robert G. Holloway,Ira Shoulson,Stanley Fahn,Karl Kieburtz,Anthony E. Lang,Kenneth Marek,Michael P. McDermott,John Seibyl,William J. Weiner,Bruno Musch,Cornelia Kamp,Mickie Welsh,Aileen Shinaman,Rajesh Pahwa,Lynn Barclay,Jean P. Hubble,Peter A. LeWitt,Janis M. Miyasaki,Oksana Suchowersky,Mark Stacy,David S. Russell,Blair Ford,John P. Hammerstad,David E. Riley,David G. Standaert,Frederick Wooten,Stewart A. Factor,Joseph Jankovic,Farah Atassi,Roger Kurlan,Michel Panisset,Ali H. Rajput,Robert L. Rodnitzky,Cliff Shults,Giselle Petsinger,Cheryl Waters,Ronald F. Pfeiffer,Kevin M. Biglan,Leona Borchert,Amy Montgomery,Laura Sutherland,Carolyn Weeks,Maryan DeAngelis,Elspeth Sime,Susan Wood,Carol Pantella,Mary Harrigan,Barbara Fussell,Sandra Dillon,Barbara Alexander-Brown,Pamela Rainey,Marsha Tennis,Elke Rost-Ruffner,Diane Brown,Sharon Evans,Debra Berry,Jean Hall,Theresa Shirley,Judith Dobson,Deborah Fontaine,Brenda Pfeiffer,Alicia Brocht,Susan E. Bennett,Susan Daigneault,Karen Hodgeman,Carolynn O'Connell,Tori Ross,Karen Richard,Arthur Watts +68 more
TL;DR: Initial treatment with pramipexole resulted in lower incidences of freezing, somnolence, and edema and provided for better symptomatic control, as measured by the Unified Parkinson's Disease Rating Scale, compared with initial treatment with levodopa, which resulted in similar quality of life.
Journal ArticleDOI
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Günter U. Höglinger,Nadine M. Melhem,Dennis W. Dickson,Patrick M. A. Sleiman,Li-San Wang,Lambertus Klei,Rosa Rademakers,Rohan de Silva,Irene Litvan,David E. Riley,John C. van Swieten,Peter Heutink,Zbigniew K. Wszolek,Ryan J. Uitti,Jana Vandrovcova,Howard I. Hurtig,Rachel G. Gross,Walter Maetzler,Stefano Goldwurm,Eduardo Tolosa,Barbara Borroni,Pau Pastor,Laura B. Cantwell,Mi Ryung Han,Allissa Dillman,Marcel P. van der Brug,J. Raphael Gibbs,J. Raphael Gibbs,Mark R. Cookson,Dena G. Hernandez,Dena G. Hernandez,Andrew B. Singleton,Matthew J. Farrer,Chang En Yu,Lawrence I. Golbe,Tamas Revesz,John Hardy,Andrew J. Lees,Bernie Devlin,Hakon Hakonarson,Ulrich Müller,Gerard D. Schellenberg,Roger L. Albin,Elena Alonso,Angelo Antonini,Manuela Apfelbacher,Steven E. Arnold,Jesús Avila,Thomas G. Beach,Sherry Beecher,Daniela Berg,Thomas D. Bird,Nenad Bogdanovic,Agnita J.W. Boon,Yvette Bordelon,Alexis Brice,Alexis Brice,Herbert Budka,Margherita Canesi,Wang Zheng Chiu,Roberto Cilia,Carlo Colosimo,Peter Paul De Deyn,Justo Garcãa De Yebenes,Laura Donker Kaat,Ranjan Duara,Alexandra Durr,Alexandra Durr,Sebastiaan Engelborghs,Giovanni Fabbrini,Nicole A. Finch,Robyn Flook,Matthew P. Frosch,Carles Gaig,Douglas Galasko,Thomas Gasser,Marla Gearing,Evan T. Geller,Bernardino Ghetti,Neill R. Graff-Radford,Murray Grossman,Deborah A. Hall,Lili-Naz Hazrati,Matthias Höllerhage,Joseph Jankovic,Jorge L. Juncos,Anna Karydas,Hans A. Kretzschmar,Isabelle Leber,Isabelle Leber,Virginia M.-Y. Lee,Andrew P. Lieberman,Kelly E. Lyons,Claudio Mariani,Eliezer Masliah,Luke A. Massey,Catriona McLean,Nicoletta Meucci,Bruce L. Miller,Brit Mollenhauer,Jens Carsten Möller,Huw R. Morris,Christopher Morris,Sean S. O'Sullivan,Wolfgang H. Oertel,Donatella Ottaviani,Alessandro Padovani,Rajesh Pahwa,Gianni Pezzoli,Stuart Pickering-Brown,Werner Poewe,Alberto Rábano,Alex Rajput,Stephen G. Reich,Gesine Respondek,Sigrun Roeber,Jonathan D. Rohrer,Owen A. Ross,Martin N. Rossor,Giorgio Sacilotto,William W. Seeley,Klaus Seppi,Laura Silveira-Moriyama,Salvatore Spina,Karin Srulijes,Peter St George-Hyslop,Maria Stamelou,David G. Standaert,Silvana Tesei,Wallace W. Tourtellotte,Claudia Trenkwalder,Claire Troakes,John Q. Trojanowski,Juan C. Troncoso,Vivianna M. Van Deerlin,Jean Paul G. Vonsattel,Gregor K. Wenning,Charles L. White,Pia Winter,Chris Zarow,Anna Zecchinelli +140 more
TL;DR: Two independent variants in MAPT affecting risk for PSP are confirmed, one of which influences MAPT brain expression and the genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface and for a myelin structural component.
Journal ArticleDOI
Cortical-basal ganglionic degeneration
David E. Riley,Anthony E. Lang,A. Lewis,L. Resch,Peter Ashby,O. Hornykiewicz,Sandra E. Black +6 more
TL;DR: This condition is more frequent than previously believed, and the diagnosis can be predicted during life on the basis of clinical findings, however, as with other "degenerative" diseases of the nervous system, a definitive diagnosis requires confirmation by autopsy.
Journal ArticleDOI
Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome.
Robert J. Maciunas,Brian N. Maddux,David E. Riley,Christina M. Whitney,Mike R. Schoenberg,Paula J. Ogrocki,Jeffrey M. Albert,Deborah J. Gould +7 more
TL;DR: Bilateral thalamic DBS appears to reduce tic frequency and severity in some patients with TS who have exhausted other available means of treatment and are likely to be medically refractory.